Form 4 · Filed Mar 5, 2026, 12:00 PM UTC
TEVA/TEVA PHARMACEUTICAL INDUSTRIES LTD
Daniell Richard — EVP, Europe Commercial
Pro feature
Read the AI thesis behind every Form 4 — only on Pro and Premium
Free accounts see filings 24 hours late and the thesis is hidden until then. Upgrade to read every Form 4 the moment it hits EDGAR, with a Sonnet-4.6 (or Opus-4.7 on flagged buys) thesis attached.
Free
FreeBrowse the last 30 days of insider filings. Weekly digest by email.
- · Last 30 days of filings (list view)
- · Conviction score badge on each filing
- · Insider profiles & edge scores
Pro
$15/moAI thesis on every filing + watchlist email alerts.
- · Full AI thesis on every Form 4 (Sonnet 4.6)
- · Full filing history (no 30-day cap)
- · Unlimited ticker watchlists
Premium
$49/moOpus 4.7 deep theses + SMS alerts + cluster-buy detection.
- · Everything in Pro
- · Opus-grade thesis on flagged buys
- · SMS alerts for highest-conviction filings
Transactions
6 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Mar 3, 2026 | M | other | 62,250 | — | — | 110,634 |
| Mar 3, 2026 | S | sell | 62,250 | $32 | $2,014,404 | 48,384 |
| Mar 3, 2026 | M | other | 141,478 | — | — | 189,862 |
| Mar 3, 2026 | S | sell | 66,735 | $32 | $2,159,538 | 123,127 |
| Mar 3, 2026 | M | other | 62,250 | $0 | — | 62,253 |
| Mar 3, 2026 | M | other | 141,478 | $0 | — | 0 |
Source: SEC EDGAR raw filing ↗ · Accession 0001193125-26-093945